• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑钠肽对川崎病冠状动脉病变风险的预测

Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.

作者信息

Kaneko Kazunari, Yoshimura Ken, Ohashi Atsushi, Kimata Takahisa, Shimo Tomohiko, Tsuji Shoji

机构信息

Department of Pediatrics, Kansai Medical University, Osaka, Japan.

出版信息

Pediatr Cardiol. 2011 Dec;32(8):1106-9. doi: 10.1007/s00246-011-9986-8. Epub 2011 Apr 13.

DOI:10.1007/s00246-011-9986-8
PMID:21487793
Abstract

Kawasaki disease (KD) is an acute systemic vasculitis associated with the development of coronary arterial lesions (CALs) occurring in 3-5% of children treated by intravenous immune globulin (IVIG). However, a considerable number of patients who are not responding to IVIG are at much higher risk. Although studies have explored potential biomarkers to predict patients with KD who are at risk of CAL, no useful single marker exists. We hypothesized that the serum concentrations of the N-terminal moiety of brain natriuretic peptide (NT-proBNP) can be useful to predict CAL. Forty-three children with KD (29 males and 14 females) were enrolled in this study. Despite IVIG, 6 of the 43 patients developed CAL. There were, however, no significant differences in variables between children with CAL and those without CAL: These include age, gender, day of the illness, leukocyte count, and the serum levels of sodium, C-reactive protein, and albumin. The serum NT-proBNP level was significantly higher in children with CAL than those without CAL (2,611 ± 1,699 vs. 1,073 ± 1,427 pg/ml; P = 0.03): the cutoff value of 1,000 pg/ml to predict CAL produced a specificity of 0.68, sensitivity of 0.83, and an odds ratio as high as 10.4. In conclusion, NT-proBNP is increased in KD patients who are developing CAL, and patients with an elevated serum NT-proBNP >1,000 pg/ml have a risk of CAL ~10 times higher than that of patients with a modest increase.

摘要

川崎病(KD)是一种急性全身性血管炎,与冠状动脉病变(CALs)的发生有关,在接受静脉注射免疫球蛋白(IVIG)治疗的儿童中,有3% - 5%会出现这种情况。然而,相当一部分对IVIG无反应的患者风险要高得多。尽管已有研究探索了潜在的生物标志物来预测有CAL风险的KD患者,但尚无有用的单一标志物。我们推测,脑钠肽N端前体(NT - proBNP)的血清浓度可能有助于预测CAL。本研究纳入了43例KD患儿(男29例,女14例)。尽管接受了IVIG治疗,43例患者中有6例出现了CAL。然而,出现CAL的儿童与未出现CAL的儿童在以下变量方面并无显著差异:这些变量包括年龄、性别、发病天数、白细胞计数以及血清钠、C反应蛋白和白蛋白水平。出现CAL的儿童血清NT - proBNP水平显著高于未出现CAL的儿童(2611±1699 vs. 1073±1427 pg/ml;P = 0.03):预测CAL的截断值为1000 pg/ml时,特异性为0.68,敏感性为0.83,优势比高达10.4。总之,正在发生CAL的KD患者NT - proBNP升高,血清NT - proBNP>1000 pg/ml的患者发生CAL的风险比轻度升高的患者高约10倍。

相似文献

1
Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.脑钠肽对川崎病冠状动脉病变风险的预测
Pediatr Cardiol. 2011 Dec;32(8):1106-9. doi: 10.1007/s00246-011-9986-8. Epub 2011 Apr 13.
2
N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.N-末端脑利钠肽前体与川崎病冠状动脉病变风险及静脉注射免疫球蛋白耐药的关系。
J Pediatr. 2013 Jun;162(6):1205-9. doi: 10.1016/j.jpeds.2012.11.026. Epub 2013 Jan 3.
3
[Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].N末端脑钠肽前体预测川崎病冠状动脉病变风险
Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):300-3.
4
Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.Pentraxin 3 水平升高与川崎病对 IVIG 的反应性和冠状动脉瘤形成相关。
Front Immunol. 2021 Apr 12;12:624802. doi: 10.3389/fimmu.2021.624802. eCollection 2021.
5
Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.北印度患有川崎病儿童的脑钠肽前体(ProBNP)水平
Rheumatol Int. 2016 Apr;36(4):551-9. doi: 10.1007/s00296-016-3430-6. Epub 2016 Feb 5.
6
Significance of Serum NT-proBNP and Endogenous H₂S for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease.血清N末端B型脑钠肽原和内源性硫化氢对预测小儿川崎病冠状动脉病变的意义
J Coll Physicians Surg Pak. 2020 Jan;30(1):37-40. doi: 10.29271/jcpsp.2020.01.37.
7
Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.川崎病幼儿冠状动脉病变的风险:对新诊断方法的需求。
Int J Rheum Dis. 2018 Mar;21(3):746-754. doi: 10.1111/1756-185X.13223. Epub 2017 Nov 3.
8
The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.年龄特异性 N 末端脑利钠肽前体 cutoff 值在预测川崎病静脉注射免疫球蛋白抵抗中的作用:一项前瞻性队列研究。
Pediatr Rheumatol Online J. 2019 Sep 18;17(1):65. doi: 10.1186/s12969-019-0368-8.
9
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.川崎病中静脉注射免疫球蛋白抵抗及冠状动脉病变的预测因素
Pediatr Rheumatol Online J. 2017 Mar 21;15(1):17. doi: 10.1186/s12969-017-0149-1.
10
A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.实验室指标在川崎病诊断中的价值的综合评估。
Arthritis Rheumatol. 2015 Jul;67(7):1943-50. doi: 10.1002/art.39112.

引用本文的文献

1
Association Between Levels of N-Terminal Pro-brain Natriuretic Peptide and Coronary Artery Lesion in Patients with Kawasaki Disease: A Systematic Review and Meta-analysis.川崎病患者N末端脑钠肽前体水平与冠状动脉病变的关联:一项系统评价和荟萃分析
Arch Rheumatol. 2025 Jun 23;40(2):256-266. doi: 10.5152/ArchRheumatol.2025.11128.
2
The relationship between N-terminal pro-brain natriuretic and coronary artery lesions in Kawasaki disease: A meta-analysis.N 端前脑钠肽与川崎病冠状动脉病变的关系:一项荟萃分析。
PLoS One. 2025 Jun 10;20(6):e0324552. doi: 10.1371/journal.pone.0324552. eCollection 2025.
3
Red blood cell distribution width predicts coronary artery lesions in Kawasaki disease: insights from a Japanese cohort.

本文引用的文献

1
Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease.在川崎病初始治疗中决定将泼尼松龙与静脉注射免疫球蛋白联合使用时的风险分层。
Pediatr Infect Dis J. 2009 Jun;28(6):498-502. doi: 10.1097/inf.0b013e3181950b64.
2
Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.利钠肽作为川崎病急性期的辅助诊断检测方法。
Pediatr Cardiol. 2009 Aug;30(6):810-7. doi: 10.1007/s00246-009-9441-2. Epub 2009 Apr 14.
3
Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
红细胞分布宽度可预测川崎病中的冠状动脉病变:来自日本队列的见解
Pediatr Rheumatol Online J. 2025 Mar 25;23(1):31. doi: 10.1186/s12969-025-01083-6.
4
Nutrition-Associated Biomarkers in Predicting Intravenous Immunoglobulin Resistance and Coronary Artery Lesions in Kawasaki Disease: A Systematic Review and Meta-Analysis.营养相关生物标志物在预测川崎病静脉注射免疫球蛋白抵抗和冠状动脉病变中的作用:一项系统评价和荟萃分析
Food Sci Nutr. 2024 Dec 15;13(1):e4647. doi: 10.1002/fsn3.4647. eCollection 2025 Jan.
5
Diagnostic performances of D-dimer, prothrombin time, and red blood cell distribution width for coronary artery lesion in children with acute stage Kawasaki disease.D - 二聚体、凝血酶原时间及红细胞分布宽度对急性期川崎病患儿冠状动脉病变的诊断效能
Front Pediatr. 2023 Jul 25;11:1141158. doi: 10.3389/fped.2023.1141158. eCollection 2023.
6
Cardiac Biomarkers in Pediatrics: An Undervalued Resource.儿科心脏生物标志物:被低估的资源。
Clin Chem. 2021 Jul 6;67(7):947-958. doi: 10.1093/clinchem/hvab063.
7
Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.Pentraxin 3 水平升高与川崎病对 IVIG 的反应性和冠状动脉瘤形成相关。
Front Immunol. 2021 Apr 12;12:624802. doi: 10.3389/fimmu.2021.624802. eCollection 2021.
8
The Importance of Serum N-Terminal Pro-Brain Natriuretic Peptide and Endogenous Hydrogen Sulfide for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease Patients: Findings From a Tertiary Care Hospital in Karachi, Pakistan.血清N末端脑钠肽前体和内源性硫化氢对预测小儿川崎病患者冠状动脉病变的重要性:来自巴基斯坦卡拉奇一家三级护理医院的研究结果
Cureus. 2020 Jul 6;12(7):e9016. doi: 10.7759/cureus.9016.
9
Structure equation model and neural network analyses to predict coronary artery lesions in Kawasaki disease: a single-centre retrospective study.结构方程模型和神经网络分析预测川崎病冠状动脉病变:单中心回顾性研究。
Sci Rep. 2020 Jul 17;10(1):11868. doi: 10.1038/s41598-020-68657-0.
10
N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease.N-末端脑利钠肽前体作为预测川崎病冠状动脉病变的生物标志物。
Sci Rep. 2020 Mar 20;10(1):5130. doi: 10.1038/s41598-020-62043-6.
川崎病相关冠状动脉异常的危险因素因年龄而异。
Eur J Pediatr. 2009 Nov;168(11):1315-21. doi: 10.1007/s00431-009-0925-0. Epub 2009 Jan 22.
4
The riddle of Kawasaki disease.川崎病之谜。
N Engl J Med. 2007 Feb 15;356(7):659-61. doi: 10.1056/NEJMp068268.
5
B-type natriuretic peptide: a critical review.B型利钠肽:一篇批判性综述。
Congest Heart Fail. 2007 Jan-Feb;13(1):48-52. doi: 10.1111/j.1527-5299.2007.05622.x.
6
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白无反应性的预测
Circulation. 2006 Jun 6;113(22):2606-12. doi: 10.1161/CIRCULATIONAHA.105.592865. Epub 2006 May 30.
7
Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease.与川崎病需要额外静脉注射γ-球蛋白治疗相关的危险因素。
Acta Paediatr. 2006 Feb;95(2):189-93. doi: 10.1080/08035250500327328.
8
N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability.N 端前脑钠肽:儿科人群的正常范围,包括方法比较和实验室间变异性。
Clin Chem Lab Med. 2006;44(1):80-5. doi: 10.1515/CCLM.2006.016.
9
Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease.脑钠肽作为川崎病患儿心室舒张功能障碍的激素标志物。
Pediatr Cardiol. 2005 Jul-Aug;26(4):425-30. doi: 10.1007/s00246-004-0812-4.
10
Kawasaki syndrome.川崎病
Lancet. 2004;364(9433):533-44. doi: 10.1016/S0140-6736(04)16814-1.